Gene expression and mutation profiling for cancer of unknown primary

被引：0
|
作者：
Hayashi, Hidetoshi [1 ]
Tomida, Shuta [2 ,3 ]
Fujita, Yoshihiko [2 ]
Togashi, Yosuke [2 ,4 ]
Sakai, Kazuko [2 ]
Nishio, Kazuto [2 ]
Nakagawa, Kazuhiko [1 ]
机构：
[1] Kindai Univ, Dept Med Oncol, Higashiosaka, Osaka, Japan
[2] Kindai Univ, Dept Genome Biol, Higashiosaka, Osaka, Japan
[3] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biobank, Okayama, Japan
[4] Natl Canc Ctr, Div Canc Immunol, Exploratory Oncol Res & Clin Trial Ctr, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ISY13-4
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Gene expression profiling may improve diagnosis in patients with carcinoma of unknown primary
    J Bridgewater
    R van Laar
    A Floore
    L Van'T Veer
    British Journal of Cancer, 2008, 98 : 1425 - 1430
  • [22] Role of Expression Profiling in Carcinoma of Unknown Primary Remains Unknown
    Saltz, Leonard B.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) : 2513 - 2514
  • [23] Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary
    M B Hannouf
    E Winquist
    S M Mahmud
    M Brackstone
    S Sarma
    G Rodrigues
    P Rogan
    J S Hoch
    G S Zaric
    The Pharmacogenomics Journal, 2017, 17 : 286 - 300
  • [24] Cost-effectiveness of using a gene expression profiling test to aid in identifying the primary tumour in patients with cancer of unknown primary
    Hannouf, M. B.
    Winquist, E.
    Mahmud, S. M.
    Brackstone, M.
    Sarma, S.
    Rodrigues, G.
    Rogan, P.
    Hoch, J. S.
    Zaric, G. S.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (03): : 286 - 300
  • [25] Clinical and pathological characteristics of cancer of unknown primary with renal profile using gene expression profiling (GEP)-based cancer classification
    Allam, Joelle
    Ma, Li
    Zhao, Jianping
    Estrella, Jeannelyn
    Higbie, Victoria
    Willett, Anneleis
    Matamoros, Aurelio
    Lano, Elizabeth A.
    Treuner, Kai
    Raghav, Kanwal Pratap Singh
    Huey, Ryan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] Gene expression profiling and its use in adenocarcinomas of unknown primary origin: A case report
    Cebollero De Miguel, Ana
    Pazo Cid, Roberto
    Martinez Trufero, Javier
    Pajares Bernad, Isabel
    Calera Urquizu, Lourdes
    Hernando Cubero, Jorge
    Anton Torres, Antonio
    ONCOLOGY LETTERS, 2015, 10 (04) : 2657 - 2661
  • [27] The use of gene expression profiling and mutation analysis increases the cost of care for patients with carcinoma of unknown primary; does it also improve survival?
    Prasad, Vinay
    Oseran, Andrew
    Fakhrejahani, Farhad
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : 159 - 162
  • [28] Role of Expression Profiling in Carcinoma of Unknown Primary Remains Unknown Reply
    Hainsworth, John D.
    Spigel, David R.
    Rubin, Mark S.
    Boccia, Ralph V.
    Greco, F. Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) : 2514 - 2515
  • [29] Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer
    Peraldo-Neia, Caterina
    Migliardi, Giorgia
    Mello-Grand, Maurizia
    Montemurro, Filippo
    Segir, Raffaella
    Pignochino, Ymera
    Cavalloni, Giuliana
    Torchio, Bruno
    Mosso, Luciano
    Chiorino, Giovanna
    Aglietta, Massimo
    BMC CANCER, 2011, 11
  • [30] Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer
    Caterina Peraldo-Neia
    Giorgia Migliardi
    Maurizia Mello-Grand
    Filippo Montemurro
    Raffaella Segir
    Ymera Pignochino
    Giuliana Cavalloni
    Bruno Torchio
    Luciano Mosso
    Giovanna Chiorino
    Massimo Aglietta
    BMC Cancer, 11
12345